Sequential Drug Delivery in Targeted Cancer Therapy

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Cancer remains a leading cause of death, with traditional therapies causing significant side effects due to damage to normal cells.
• Targeted drug delivery platforms aim to overcome limitations of free therapeutics and biological barriers in cancer treatment.
• Existing strategies target cancer cell surface markers like CD44 and folate receptors, but intracellular delivery to specific organelles is also crucial.

Purpose of the Study:

• To review and classify sequential drug delivery systems based on their final targeted organelles.
• To summarize various cellular- and subcellular-level targeting strategies and their mechanisms.
• To highlight the promise of dual-targeting delivery systems for enhanced cancer therapy and overcoming drug resistance.

Main Methods:

• Classification of sequential drug delivery systems according to their final targeted organelles.
• Summary of diverse targeting strategies, including cell surface and intracellular organelle targeting.
• Review of mechanisms employed for active drug delivery within cells.

Main Results:

• Identification of common cancer cell surface targets (e.g., CD44, folate receptors).
• Examples of subcellular targeting strategies for organelles like the nucleus and Golgi apparatus.
• Emphasis on the effectiveness of sequential delivery for simultaneous cellular and subcellular targeting.

Conclusions:

• Dual-targeting drug delivery systems, achieving both cellular and subcellular specificity, hold significant promise for improving cancer treatment outcomes.
• Sequential drug delivery enhances therapeutic efficacy and can help overcome challenges like drug resistance.
• Further development of these advanced delivery systems is crucial for more effective cancer therapies.